Debrecen, Hungary

Ferenc Vinczi

This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszergyar Rt.. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ferenc Vinczi: Innovator in Pharmaceutical Chemistry

Introduction

Ferenc Vinczi is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of high-purity deferoxamine salts. His innovative work has implications for medical treatments and drug formulations.

Latest Patents

Ferenc Vinczi holds a patent for a "Process for the preparation of high-purity deferoxamine salts." This process involves the extraction of deferoxamine B from filtered fermentation liquors using ion exchange resins. The method includes the purification of the active ingredient through salting out techniques, ensuring high purity levels for pharmaceutical applications.

Career Highlights

Vinczi's career is marked by his dedication to advancing pharmaceutical processes. His work at Biogal Gyogyszergyar Rt. has positioned him as a key player in the development of effective drug formulations. His innovative approach to purification processes has garnered attention in the pharmaceutical industry.

Collaborations

Ferenc Vinczi has collaborated with esteemed colleagues such as Zoltan Konyari and Vilmos Keri. These partnerships have fostered a collaborative environment that enhances research and development efforts in their field.

Conclusion

Ferenc Vinczi's contributions to pharmaceutical chemistry through his innovative patent demonstrate his commitment to improving drug formulation processes. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…